Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 7,656 | 10,271 | 13,493 | 3,502 | 3,311 |
| Gross Profit | 7,656 | 10,271 | 13,493 | 3,502 | 3,311 |
| Operating Expenses | 22,833 | 22,896 | 21,448 | 15,738 | 14,134 |
| Operating Income | -15,177 | -12,625 | -7,955 | -12,236 | -10,823 |
| Interest Expense | 2 | 19 | 85 | 129 | 81 |
| Other Income | 1,120 | 1,639 | 1,820 | 2,426 | 2,896 |
| Pre-tax Income | -14,059 | -11,005 | -6,220 | -9,939 | -8,008 |
| Net Income Continuous | -14,059 | -11,005 | -6,220 | -9,939 | -8,008 |
| Net Income | $-14,059 | $-11,005 | $-6,220 | $-9,939 | $-8,008 |
| EPS Basic Total Ops | -1.89 | -1.47 | -0.84 | -1.40 | -1.19 |
| EPS Basic Continuous Ops | -1.89 | -1.47 | -0.85 | -1.42 | -1.16 |
| EPS Diluted Total Ops | -1.89 | -1.47 | -0.84 | -1.40 | -1.19 |
| EPS Diluted Continuous Ops | -1.89 | -1.47 | -0.85 | -1.42 | -1.16 |
| EBITDA(a) | $-12,957 | $-10,514 | $-6,302 | $-11,174 | $-9,869 |